Tissue-specific, non-invasive toxicity biomarkers: translation from preclinical safety assessment to clinical safety monitoring

Impaired Tubular Uptake Explains Albuminuria in Early Diabetic Nephropathy

(2009) L. M. Russo et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Comparative Analysis of Novel Noninvasive Renal Biomarkers and Metabonomic Changes in a Rat Model of Gentamicin Nephrotoxicity

(2009) Max Sieber et al.   TOXICOLOGICAL SCIENCES

Drug-induced phospholipidosis is caused by blockade of mannose 6-phosphate receptor-mediated targeting of lysosomal enzymes

(2008) Kazuhiko Ikeda et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Urine NGAL Predicts Severity of Acute Kidney Injury After Cardiac Surgery: A Prospective Study

(2008) M. Bennett et al.   Clinical Journal of the American Society of Nephrology

Biomarkers in oncology drug development: rescuers or troublemakers?

(2008) Estelle Marrer et al.   Expert Opinion on Drug Metabolism & Toxicology

Marked elevation of serum mitochondrion-derived markers in mild models of non-alcoholic steatohepatitis in rats

(2008) Hiroshi Murayama et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

The Circulating Inactive Form of Matrix Gla Protein (ucMGP) as a Biomarker for Cardiovascular Calcification

(2008) Ellen C.M. Cranenburg et al.   JOURNAL OF VASCULAR RESEARCH

Strategic Approach to Fit-for-Purpose Biomarkers in Drug Development

(2007) John A. Wagner   Annual Review of Pharmacology and Toxicology

NGAL (neutrophil gelatinase-associated lipocalin) and cystatin C: Are they good predictors of contrast nephropathy after percutaneous coronary interventions in patients with stable angina and normal serum creatinine?

(2007) H. Bachorzewska-Gajewska et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

The current state of serum biomarkers of hepatotoxicity

(2007) Josef Ozer et al.   TOXICOLOGY